Attached files
| file | filename |
|---|---|
| EX-99 - EXHIBIT 99 - AmeriCann, Inc. | ex_133666.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): January 30, 2019
AMERICANN, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 000-54231 | 27-4336843 | ||
| (State or other jurisdiction | (Commission File No.) | (IRS Employer | ||
| of incorporation) | Identification No.) |
|
1550 Wewatta St. 2nd Floor, Denver, CO 80202 |
||
| (Address of principal executive offices, including Zip Code) |
Registrant's telephone number, including area code: (303) 862-9000
| (Former name or former address if changed since last report) |
Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below)
|
[ ] |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
[ ] |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
[ ] |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
[ ] |
Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 8.01. |
Other Events |
Massachusetts Construction Update
On January 30, 2019 the Company issued a press release providing an update on construction progress at the Company’s Massachusetts Medical Cannabis Center.
The Massachusetts Medical Cannabis Center is being developed on a 52-acre parcel located in Southeastern Massachusetts. The MMCC project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure, which will be developed in phases, and plans to support both the existing medical cannabis and the newly emerging adult-use cannabis marketplace.
AmeriCann plans to replicate the brands, technology and innovations developed at its MMCC project to new markets as a licensed multi-state operator (MSO).
A copy of the press release is attached as Exhibit 99.
|
Item 9.01. |
Financial Statements and Exhibits |
|
Number |
Description |
| 99 | Press Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 30, 2019
|
|
AMERICANN, INC. |
|
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
Timothy Keogh, Chief Executive Officer |
|
|
|
|
|
|
3